^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Hodgkin Lymphoma
    Regimen:BEACOPP (bleomycin + cyclophosphamide + doxorubicin hydrochloride + etoposide IV + Matulane (procarbazine hydrochloride) + + vincristine)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Published date:
    11/19/2021
    Excerpt:
    Hodgkin Lymphoma: Useful in certain circumstances...Escalated BEACOPP